CERUS CORP Debt Securities, Available-for-Sale, Amortized Cost, Maturity, Allocated and Single Maturity Date, after Year One Through Five
CERUS CORP (CERS) had Debt Securities, Available-for-Sale, Amortized Cost, Maturity, Allocated and Single Maturity Date, after Year One Through Five of $15.42 million as of 2026-06-30, per its 10-Q filed 2026-07-30.
Financial Statements › Notes › Debt and Equity Securities › Available-for-Sale Securities, Debt Maturities › Debt Securities, Available-for-Sale, Maturity, Allocated and Single Maturity Date, Amortized Cost
us-gaap:AvailableForSaleSecuritiesDebtMaturitiesAfterOneThroughFiveYearsAmortizedCost · last filed 2026-07-30
- 2026-06-30: Debt Securities, Available-for-Sale, Amortized Cost, Maturity, Allocated and Single Maturity Date, after Year One Through Five $15.42M.
- 2026-03-31: Debt Securities, Available-for-Sale, Amortized Cost, Maturity, Allocated and Single Maturity Date, after Year One Through Five $16.65M.
- 2025-12-31: Debt Securities, Available-for-Sale, Amortized Cost, Maturity, Allocated and Single Maturity Date, after Year One Through Five $18.68M.
- 2025-09-30: Debt Securities, Available-for-Sale, Amortized Cost, Maturity, Allocated and Single Maturity Date, after Year One Through Five $11.40M.
| Period end | Debt Securities, Available-for-Sale, Amortized Cost, Maturity, Allocated and Single Maturity Date, after Year One Through Five |
|---|---|
| 2026-06-30 | $15.42M 10-Q · filed 2026-07-30 |
| 2026-03-31 | $16.65M 10-Q · filed 2026-04-30 |
| 2025-12-31 | $18.68M 10-Q · filed 2026-07-30 |
| 2025-09-30 | $11.40M 10-Q · filed 2025-11-06 |
| 2025-06-30 | $17.80M 10-Q · filed 2025-08-05 |
| 2025-03-31 | $20.05M 10-Q · filed 2025-05-01 |
| 2024-12-31 | $24.09M 10-K · filed 2026-03-02 |
| 2024-09-30 | $22.90M 10-Q · filed 2024-10-31 |
| 2024-06-30 | $20.89M 10-Q · filed 2024-08-01 |
| 2024-03-31 | $16.31M 10-Q · filed 2024-05-02 |
| 2023-12-31 | $17.86M 10-K · filed 2025-02-26 |
| 2023-09-30 | $37.50M 10-Q · filed 2023-11-02 |
| 2023-06-30 | $47.09M 10-Q · filed 2023-08-03 |
| 2023-03-31 | $53.21M 10-Q · filed 2023-05-04 |
| 2022-12-31 | $55.54M 10-K · filed 2024-03-05 |
| 2022-09-30 | $57.04M 10-Q · filed 2022-11-03 |
| 2022-06-30 | $51.04M 10-Q · filed 2022-08-04 |
| 2022-03-31 | $42.81M 10-Q · filed 2022-05-05 |
| 2021-12-31 | $43.05M 10-K · filed 2023-03-01 |
| 2021-09-30 | $10.14M 10-Q · filed 2021-11-02 |
| 2021-06-30 | $17.27M 10-Q · filed 2021-08-03 |
| 2021-03-31 | $25.46M 10-Q · filed 2021-05-04 |
| 2020-12-31 | $37.67M 10-K · filed 2022-02-22 |
| 2020-09-30 | $42.78M 10-Q · filed 2020-10-29 |
| 2020-06-30 | $49.86M 10-Q · filed 2020-08-04 |
| 2020-03-31 | $55.81M 10-Q · filed 2020-05-05 |
| 2019-12-31 | $15.66M 10-K · filed 2021-02-25 |
| 2019-09-30 | $12.57M 10-Q · filed 2019-10-30 |
| 2019-06-30 | $22.57M 10-Q · filed 2019-08-01 |
| 2018-12-31 | $9.94M 10-K · filed 2020-02-21 |
| 2018-09-30 | $28.03M 10-Q · filed 2018-11-01 |
| 2018-06-30 | $47.00M 10-Q · filed 2018-08-02 |
| 2018-03-31 | $62.62M 10-Q · filed 2018-05-08 |
| 2017-12-31 | $12.03M 10-K · filed 2019-02-27 |
| 2017-09-30 | $6.01M 10-Q · filed 2017-11-03 |
| 2016-09-30 | $4.00M 10-Q · filed 2016-11-04 |
| 2016-06-30 | $10.11M 10-Q · filed 2016-08-05 |
| 2016-03-31 | $20.18M 10-Q · filed 2016-05-06 |
| 2015-03-31 | $0.00 10-Q · filed 2015-05-08 |
| 2014-12-31 | $5.71M 10-K · filed 2016-03-09 |
| 2013-12-31 | $6.13M 10-K · filed 2015-03-16 |
| 2013-09-30 | $12.36M 10-Q · filed 2013-11-01 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| TACTILE SYSTEMS TECHNOLOGY INC (TCMD) | United States | $0.519B | 27.16 |
| DELCATH SYSTEMS, INC. (DCTH) | United States | $0.558B | 820.33 |
| NeuroPace Inc (NPCE) | United States | $0.480B | -28.52 |
| Sight Sciences, Inc. (SGHT) | United States | $0.478B | -9.95 |
| SS Innovations International, Inc. (SSII) | $0.589B | -64.06 | |
| ORTHOPEDIATRICS CORP (KIDS) | United States | $0.592B | |
| ClearPoint Neuro, Inc. (CLPT) | United States | $0.446B | -15.74 |
| ANGIODYNAMICS INC (ANGO) | United States | $0.632B | -13.02 |
| CARLSMED, INC. (CARL) | United States | $0.405B | |
| Orthofix Medical Inc. (OFIX) | $0.373B |